K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Quick facts

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc portfolio CI brief
• K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc pipeline updates RSS

Related

• Sector hub: All tracked pharma companies